Drug Profile


Alternative Names: FG 5606

Latest Information Update: 11 Jan 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmacia Corporation
  • Class Antidepressants; Antipsychotics; Piperazines; Small molecules
  • Mechanism of Action Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Drug abuse; Psychotic disorders

Most Recent Events

  • 11 Jan 1999 Discontinued-Phase-Unspecified for Drug abuse in Sweden (Unspecified route)
  • 11 Jan 1999 Discontinued-Phase-Unspecified for Drug abuse in USA (Unspecified route)
  • 09 Dec 1994 Discontinued-III for Psychotic disorders in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top